Botanix Pharmaceuticals Limited BXPHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.43M | -52.22M | -56.94M | -56.11M | -55.60M |
| Total Depreciation and Amortization | 1.57M | 1.54M | 1.50M | 1.48M | 1.47M |
| Total Amortization of Deferred Charges | 1.72M | 2.49M | 3.24M | 3.24M | 3.24M |
| Total Other Non-Cash Items | 6.11M | 10.44M | 14.69M | 13.86M | 13.03M |
| Change in Net Operating Assets | -5.91M | -9.38M | -12.77M | -12.77M | -12.77M |
| Cash from Operations | -43.93M | -47.13M | -50.28M | -50.30M | -50.64M |
| Capital Expenditure | 200.00 | -63.30K | -125.50K | -154.30K | -183.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -266.60K | -277.40K | -287.90K | -392.40K | -504.50K |
| Cash from Investing | -266.50K | -340.80K | -413.50K | -546.80K | -688.40K |
| Total Debt Issued | -- | 14.20M | 28.40M | 28.40M | 28.40M |
| Total Debt Repaid | -3.02M | -1.68M | -337.00K | -264.80K | -192.60K |
| Issuance of Common Stock | 45.02M | 42.52M | 40.02M | 40.24M | 40.46M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.42M | -5.55M | -5.68M | -4.49M | -3.31M |
| Cash from Financing | 25.80M | 32.71M | 39.51M | 40.47M | 41.44M |
| Foreign Exchange rate Adjustments | 69.70K | -61.00K | -188.90K | -113.40K | -36.70K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -18.33M | -14.82M | -11.38M | -10.49M | -9.92M |